Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population

被引:0
|
作者
Bozina, N
Granic, P
Lalic, Z
Tramisak, I
Lovric, M
Stavljenic-Rukavina, A
机构
[1] Univ Zagreb, Ctr Hosp, Univ Inst Lab Diag, Zagreb 10000, Croatia
[2] Sch Med, Zagreb, Croatia
关键词
alleles; Croatia; cytochrome P450 enzyme system; genotype; phenotype; polymorphism (genetics);
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To determine the prevalence of most common mutations of cytochrome P450 (CYP), ie, allelic variants of CYP2C9, CYP2C19, and CYP2D6, and to predict genotype frequency in the Croatian population. Methods. CYP genotype was determined in 200 non-related Croatian citizens. DNA isolated from blood samples was used for the analysis of the most common allelic variants of CYP2C9, CYP2C19, and CYP2D6 by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results. For 200 subjects genotyped for CYP2C9, the allele frequencies of CYP2C9*1 (wt), CYP2C9*2, and CYP2C9*3 were 0.74 0.165 and 0.095, respectively. Among them, 3.5% of subjects were predicted to be poor metabolizers. For CYP2C19, the most frequent alleles were CYP2C19*1 and CYP2C19*2, with frequencies of 0.85 and 0.15 respectively; 3% of subjects were predicted to be poor metabolizers. For CYP2D6, the most frequent alleles were CYP2D6*1 (frequency 0.765), CYP2D62* (0.04), CYP2D6*3 (0.0275), CYP2D6*4 (0.14), CYP2D6*5 (0.01), and CYP2D6*6 (0.015). Out of these, 3% were predicted to be poor metabolizers, and 4% were predicted to be ultra-rapid metabolizers. Conclusion. The prevalence of allelic variants and predicted genotypes in the Croatian population is in accordance with the other European populations, and it can be interpolated between the values for mid-European and Mediterranean populations.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 50 条
  • [41] Correlation of genotype, phenotype, and mRNA expression of CYP2D6 and CYP2C19 in peripheral blood leukocytes
    Kuhlmann, Jan B.
    Wensing, Georg
    Kuhlmann, Jochen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (02) : 143 - 150
  • [42] Genetic polymorphisms of CYP2C19 in ecuadorian population: An interethnic approach
    Llorente, Alba Alonso
    Garrido, Josefa Salgado
    Hermida, Oscar Teijido
    Andrade, Fabricio Gonzalez
    Martin, Alberto Valiente
    Villacampa, Ana Julia Fanlo
    Romero, Jorge Vicente
    HELIYON, 2024, 10 (07)
  • [43] Dose regimens for Chinese adult liver transplant recipients according to the genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in recipients and donors
    Zhu, Liqin
    Liao, Shasha
    Wang, Nan
    Ge, Tingyue
    Yang, Jianwei
    Xu, Gaoqi
    Wang, Jianhai
    Li, Keqiu
    Li, Guang
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (08) : 587 - 596
  • [44] Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19
    Koopmans, Anne B.
    Braakman, Mario H.
    Vinkers, David J.
    Hoek, Hans W.
    van Harten, Peter N.
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [45] Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
    Abudukeremu, Muzhapaer
    Ayoufu, Aisikaer
    Tuerhong, Adila
    Paizula, Xuelaiti
    Ou, Jiang-Hua
    OPEN LIFE SCIENCES, 2024, 19 (01):
  • [46] Relationship between the susceptibility for subacute myelo-optico-neuropathy (SMON) and polymorphisms of CYP2D6 and CYP2C19
    Sakae, Y
    Iwahashi, K
    Nakamura, K
    Usuki, T
    Watanabe, M
    Hayahara, T
    Ameno, K
    Suwaki, H
    JAPANESE JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1997, 43 (06): : 376 - 382
  • [47] Correlation between cytochrome P-450CYP2D6 CYP2D6) genotype and phenotype
    Chen, SQ
    Wedlund, PJ
    ACTA PHARMACOLOGICA SINICA, 1999, 20 (07): : 585 - 588
  • [48] Quantitative Modeling Analysis Demonstrates the Impact of CYP2C19 and CYP2D6 Genetic Polymorphisms on the Pharmacokinetics of Amitriptyline and Its Metabolite, Nortriptyline
    Koh, Ara
    Pak, Kwan Cheol
    Choi, Hee Youn
    Ryu, Sunae
    Choi, Seung-eun
    Kim, Ki Soon
    Bae, Kyun-Seop
    Lim, Hyeong-Seok
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (04) : 532 - 540
  • [49] Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran
    Negar Azarpira
    Soha Namazi
    Fatemeh Hendijani
    Maryam Banan
    Masumeh Darai
    Pharmacological Reports, 2010, 62 : 740 - 746
  • [50] Celecoxib is a substrate of CYP2D6: Impact on celecoxib metabolism in individuals with CYP2C9*3 variants
    Siu, Y. Amy
    Hao, Ming-Hong
    Dixit, Vaishali
    Lai, W. George
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (05) : 219 - 227